← Open Payments lookup

RONALD MCFADDEN: Open Payments

NPI 1285718734 · CLARION, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,044 in 109 payments from 14 companies in 2025. Trend: 2023 $29,616 · 2024 $19,286 · 2025 $2,044

Food & beverage: $1,966Education: $78
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.17$327
ABBVIE INC.19$268
Vanda Pharmaceuticals Inc.7$196
Alkermes, Inc.13$186
Neurocrine BioSciences, Inc.9$180
Otsuka America Pharmaceutical, Inc.8$169
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$163
Axsome Therapeutics, Inc.8$155
Collegium Pharmaceutical, Inc.5$112
Takeda Pharmaceuticals U.S.A., Inc.5$91

Products named: VRAYLAR, REXULTI, ARISTADA, INGREZZA, FANAPT, UZEDY, CAPLYTA, Auvelity.

Industry payments across PA — which companies pay providers there.